Board committees

Board of Directors:

Anders Ekblom

Chairman of the Board

Chairman of the Board since 2021
Chairman of the Remuneration Committee
Born 1954

Education: M.D., Board certified in Anesthesiology and Intensive Care, D.D.S., Associate Professor in Physiology, Karolinska Institutet

Other current activities: Chairman of the Board of Alligator Bioscience AB, Atrogi AB, and Elypta AB, Member of the Board of AnaMar AB, Flerie Invest AB, Mereo BioPharma Goup Plc, and Deputy director of Xspray Pharma Futurum AB

Previous assignments (the recent 5 years): Chairman of the Board of TFS International AB, member of the Board of Infant Bacterial Therapy AB, and Medivir AB

Holdings: 4,500 shares, 13 214 warrants (LTIP 2021/2026), 500 warrants (TO6)

Independent in relation to the Company and its management, but not in relation to major shareholders

Anders Bladh

Board member since 2021

Member of the Remuneration Committee
Born 1958

Education: Bachelor of Science in Business Administration and Economics, University of Uppsala

Other current activities: Owner, member of the Board, as well as CEO of Intervalor AB, Ribbskottet AB, and Rimturs AB, as well as member of the Board of DistIT AB

Holdings: 217,321 shares, 24,145 warrants (TO6), and 3,600,000 shares via company Ribbskottet AB

Independent in relation to the Company and its management, but not in relation to major shareholders.

Maris Hartmanis

Board member

Board member since 2015
Chairman of the Audit Committee
Born 1953

Education: Ph.D. in Biochemistry and Associate Professor, Kungliga Tekniska Högskolan (Royal Institute of Technology)

Other current activities: CEO and Chairman of the research foundation FINGERS Brain Health Institute and Affiliated Professor, Karolinska Institutet

Previous assignments (the recent 5 years): CEO and Chairman of the Board of Hartmanis & Partners AB, Board member of BioLamina, Xbrane Biopharma AB, and Applied Photophysics Ltd., England

Holdings: 35,774 shares, 2,385 warrants (TO6)

Independent in relation to the Company and its management and in relation to major shareholders

Torbjörn Koivisto

Board member

Board member since 2017
Member of the Remuneration Committee
Born 1969

Education: Master of Laws (LL.M.), University of Uppsala

Other current activities: Other current activities: Board member of Cinclus Pharma Holding AB, Cinclus Pharma AB, and IARU Institutet för Affärsjuridisk Rådgivning I Uppsala AB, as well as deputy of RJC Roger Johansson Consulting AB, and Virdings Allé Invest AB

Previous assignments (the recent 5 years): Board member of Moberg Pharma AB, Hemcheck Sweden AB, and partner in KOL Arts & Craft Handelsbolag

Holdings: 9,000 shares, and 1,000 warrants (TO6) via company (IARU)

Independent in relation to the Company and its management and in relation to major shareholders

Christine Lind

Board member

Board member since 2019
Member of the Audit Committee
Born 1974

Education: Bachelors in Science in Finance and information Systems, New York University, Masters in Business Administration in Finance and Management, Columbia Business School

Other current activities: Other current activities: VP Commercial of NDA Group AB, chairman and CEO of Lind Growth Strategy AB, chairman of the board in Mendus AB and deputy board member of Shinka Life Sciences AB

Previous assignments (the recent 5 years): CEO as well as EVP Business Development of Medivir AB

Holdings: 5,998 shares, 666 warrants (TO6)

Independent in relation to the Company and its management and in relation to major shareholders

Robert Molander

Board member

Board member since 2022
Resides in the USA
Born 1965

Education: MBA from Washington University and two bachelor’s degrees from Miami University in Economics and International Studies

Other current activities: CEO of Stratfox Healthcare Group LLC

Previous assignments (the recent 5 years): CCO of Infant Bacterial Therapeutics AB, Board member of Infant Bacterial Therapeutics AB, CCO of Trialbee AB

Holdings: 5,000 shares

Independent in relation to the Company and its management and in relation to major shareholders

Carl-Johan Spak

Board member

Board member since 2015
Member of the Audit Committee
Born 1956

Education: Dr. of Odontology, Degree in Dentistry, Karolinska Institutet

Other current activities: Board member of Provell Pharmaceuticals LLC, Atrogi AB, EpiEndo ehf, KAHR Medical Ltd., Pharmacolog
i Uppsala AB, Lipum AB, and Symcel AB, and deputy in Buzzard Pharmaceuticals AB

Previous assignments (the recent 5 years): Chairman of the board in Cobra Biologics Holdings AB, Follicum AB, Recipharm OT Chemistry AB and Recipharm Pharmaceutical Development AB, and Bostadsrättsföreningen Smultronhyllan, Board member of Empros Pharma AB,Prokarium Ltd., SwedenBIO Service AB, Synthonics, Inc., Pharmanest AB, Inject Pharma Sweden AB, Binx Health Ltd., UK, Recipharm OT Chemistry AB och Recipharm Strängnäs AB, member of board as well as CEO of Recipharm Venture Fund AB, and RPH Pharmaceuticals AB, and deputy member of the board in Cobra Biologics AB.

Holdings: None

Independent in relation to the Company and its management and in relation to major shareholders

Committees:

Audit Committee

  • Maris Hartmanis, Chairman
  • Christine Lind
  • Carl-Johan Spak

Remuneration Committee

  • Anders Ekblom, Chairman
  • Anders Bladh
  • Torbjörn Koivisto